| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gambogic acid is a naturally occurring xanthonoid extracted from the resin of trees belonging to the Garcinia genus—most notably, Garcinia hanburyi. This tree is native to regions in Southeast Asia, particularly found in areas of China, India, and neighboring countries. Gambogic acid (GA; C38H44O8, MW: 628.76), a polyprenylated xanthone and a widely used coloring agent, is the main active ingredient of gamboges secreted from the Garcinia hanburyi tree ([3, 4], which mainly grows in Southeast Asia. GA has been approved by the Chinese FDA for the treatment of solid cancers in Phase II clinical trials. Pathways: -evidence suggesting that it can inhibit thioredoxin reductase (TrxR). -can indeed lead to an increase in reactive oxygen species (ROS) levels -Gambogic acid can trigger mitochondrial dysfunction, leading to cytochrome c release -influences death receptors -Inhibition of NF-κB Signaling -Inhibition of VEGF Pathway -Cell Cycle Arrest: -p53 Activation
|
| Source: HalifaxProj(suppress signaling);CGL-Driver Genes |
| Type: Oncogene |
| Androgens play an important role in the proliferation, differentiation, maintenance and function of the prostate [1]. Intriguingly, they may also be involved in the development and progression of prostate cancer. Androgen deprivation therapy can suppress hormone-naïve prostate cancer, but prostate cancer changes AR and adapts to survive under castration levels of androgen. The prognostic significance of androgen receptor expression varies widely across different cancer types. In some cancers, high AR expression is associated with poor outcomes, while in others, it may indicate a better prognosis High expression with poor prognosis is most common. AR is used as a clinical biomarker for prostate therapy |
| 1955- | GamB, | Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancer |
| - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | DU145 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:302 Target#:15 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid